03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Lyxumia 10µg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Sanofi Aventis Groupe |
Origin | France |
Manufacturer | Sanofi Aventis Deutschland GmbH |
Origin | Germany |
ATC | A10BJ03 |
Lyxumia 10µg* :
Lyxumia 10µg* :
Lyxumia 10µg* :
Lyxumia 10µg* :
Lyxumia 10µg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Lyxumia 10µg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Anaphylactic reactions | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Arrhythmia | Not known |
Back pain | Common |
Cystitis | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Drug specific antibody present | Not known |
Dyspepsia | Common |
Headache | Very Common |
Heart rate increased | Not known |
Hypoglycaemia | Very Common |
Influenza | Common |
Injection site pruritus | Common |
Nausea | Very Common |
Palpitations | Not known |
Somnolence | Common |
Tachycardia | Not known |
Upper respiratory tract infection | Common |
Urticaria | Uncommon |
Viral infection | Common |
Vomiting | Very Common |
Lyxumia 10µg* :
NB : Products With Same Indication |
Different Units By MoH Code
Lyxumia 10µg* MoH 7565 :
Form | Solution for injection |
Packaging | Disposable pen with cartridge (Type I glass) |
Package Size | 1x3ml |
Strength | 10µg/0.2ml |
Storage Condition | 2-8°C Do not freeze |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 187059/13 |
Submission date | 01/01/2013 |
Registration Year | 2014 |
Archived Date | 02/03/2020 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 259 QAR | ( 6,360,522.00 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 18,5 QAR | ( 442,044.00 LBP ) |
● Pharmacy Price: | 212.3176575 QAR | ( 5214097.032885 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 255.5 AED | ( 6,173,135.50 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 18,25 AED | ( 434,898.00 LBP ) |
● Pharmacy Price: | 205.75 AED | ( 4971125.75 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 3ml Pre-filled Pen | |
● Public Price: | 255.5 AED | ( 6,173,135.50 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 18,25 AED | ( 434,898.00 LBP ) |
● Pharmacy Price: | 205.75 AED | ( 4971125.75 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Denmark | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 462.35 DKK | ( 5,999,453.60 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 33,025 DKK | ( 428,208.00 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Italy | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 56.12 EUR | ( 5,436,681.12 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 4,0086 EUR | ( 387,504.00 LBP ) |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 62.29 EUR | ( 6,034,406.04 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 4,4493 EUR | ( 387,504.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 1222.34 CZK | ( 4,668,116.46 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 87,31 CZK | ( 332,253.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 42.65 EUR | ( 4,131,761.40 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 3,0464 EUR | ( 290,628.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 3ml | |
● Public Price: | 155 SAR | ( 3,664,200.00 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 11,0714 SAR | ( 260,040.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 36.14 JOD | ( 4,525,486.94 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 2,5814 JOD | ( 250,442.00 LBP ) |
● Pharmacy Price: | 27.58 JOD | ( 3453595.18 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 22/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 432.8 NOK | ( 3,507,411.20 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 30,9143 NOK | ( 243,120.00 LBP ) |
● Pharmacy Price: | 309.54 NOK | ( 2508512.16 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Withdrawn |
● Country: | Oman | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 27.22 OMR | ( 6,280,579.48 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 1,9443 OMR | ( 230,734.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1x3ml (14doses) | |
● Public Price: | 31.67 GBP | ( 3,599,263.83 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 2,2621 GBP | ( 227,298.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Germany |
● Package Size: | 1x3ml |
● Medica Comments: | Not available in the country of origin |
● Pricing Date: | 20/10/2020 |
● Type: | Medicine not available |
● Country: | Finland |
● Package Size: | 1x3ml (14doses) |
● Reference: | Kela |
● Pricing Date: | 22/04/2021 |
● Type: | Medicine Non Marketed |
● Country: | Greece |
● Package Size: | 1x3ml (14doses) |
● Reference: | National Organization for Medicines |
● Pricing Date: | 25/03/2019 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File